Cargando…

Decoding γδ T cell anticancer therapies: integrating CRISPR screens with tumor organoids

Detalles Bibliográficos
Autores principales:	Zhou, Jian, Wu, Min, Yang, Gen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641060/ https://www.ncbi.nlm.nih.gov/pubmed/37953309 http://dx.doi.org/10.1038/s41392-023-01678-z

Ejemplares similares

Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity
por: Lopes, Noëlla, et al.
Publicado: (2020)

Combination therapy for HCC: from CRISPR screening to the design of clinical therapies
por: Wang, Yunguang, et al.
Publicado: (2021)

Organoid-based chemical approach to dissect the mechanism controlling cellular dynamics
por: Lacko, Lauretta A, et al.
Publicado: (2019)

Thymus medulla fosters generation of natural Treg cells, invariant γδ T cells, and invariant NKT cells: What we learn from intrathymic migration
por: Cowan, Jennifer E, et al.
Publicado: (2015)

ELANE: an emerging lane to selective anticancer therapy
por: Peng, Boqiang, et al.
Publicado: (2021)

Protein stability regulators screening assay (Pro-SRSA): protein degradation meets the CRISPR–Cas9 library
por: Wu, Yuanzhong, et al.
Publicado: (2016)

CRISPR base editor treats premature-aging syndrome
por: Lin, Ping, et al.
Publicado: (2021)

A WIMSical approach to decoding DNA methylation in myeloid leukemia
por: Guryanova, Olga A, et al.
Publicado: (2014)

The Vγ4/butyrophilin conspiracy: novel role of intraepithelial γδ T cells in chronic inflammatory bowel disease
por: Kabelitz, Dieter
Publicado: (2023)

CRISPR sabotage
por: van der Oost, John, et al.
Publicado: (2015)

Decode protein-metabolite regulatory network: one MIDAS at a time
por: Liu, Tian, et al.
Publicado: (2023)

Human liver organoid: modeling liver steatosis and beyond
por: Wei, Jinsong, et al.
Publicado: (2023)

CRISPR-mediated RNA base editing: a promising strategy to rescue deafness
por: Liu, Wenyi, et al.
Publicado: (2023)

Organoids demonstrate gut infection by SARS-CoV-2
por: Dickson, Iain
Publicado: (2020)

Targeting mitochondria as an anticancer strategy
por: Dong, Lanfeng, et al.
Publicado: (2019)

The Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting
por: Li, Yang, et al.
Publicado: (2021)

Research on ADR1s helps understanding the plant immune network
por: Hu, Meijuan, et al.
Publicado: (2022)

Boosting plant immunity with CRISPR/Cas
por: Chaparro-Garcia, Angela, et al.
Publicado: (2015)

The continuously evolving CRISPR barcoding toolbox
por: Gaj, Thomas, et al.
Publicado: (2018)

CRISPR enables directed evolution in plants
por: Zhang, Yingxiao, et al.
Publicado: (2019)

Tumor‐derived microparticles in tumor immunology and immunotherapy
por: Ma, Jingwei, et al.
Publicado: (2020)

SARS-CoV-2 infection of kidney organoids prevented with soluble human ACE2
por: Allison, Susan J.
Publicado: (2020)

A CRISPR way to engineer the human genome
por: Ramalingam, Sivaprakash, et al.
Publicado: (2013)

A CRISPR design for next-generation antimicrobials
por: Beisel, Chase L, et al.
Publicado: (2014)

Understanding and repurposing CRISPR-mediated alternative splicing
por: Smith, Jordan L., et al.
Publicado: (2018)

The best protection is early detection: Fostering timely and accurate screening
por: Kattner, Aila Akosua
Publicado: (2021)

Research highlights for issue 6: the CRISPR/Cas revolution
por: Koskella, Britt
Publicado: (2015)

Using CRISPR to understand how cancer mutations happen
por: Rogers, Eve H.
Publicado: (2021)

The first human trial of CRISPR-based cell therapy clears safety concerns as new treatment for late-stage lung cancer
por: He, Shenghui
Publicado: (2020)

Decoding molnupiravir-induced mutagenesis in SARS-CoV-2
por: Menéndez-Arias, Luis
Publicado: (2021)

Artificial intelligence-assisted niacin skin flush screening in early psychosis identification and prediction
por: Chen, Tao, et al.
Publicado: (2022)

Margetuximab: An active alternative for later‐line therapy in patients with HER2‐positive advanced breast cancer
por: Zhou, Yunxiang, et al.
Publicado: (2023)

Radiotherapy and the tumor microenvironment: The “macro” picture
por: Walton, Emma Louise
Publicado: (2017)

On the road to epigenetic therapy
por: Walton, Emma L.
Publicado: (2016)

CRISPR-mediated genome editing of Plasmodium falciparum malaria parasites
por: Lee, Marcus CS, et al.
Publicado: (2014)

Unexpected consequences: exon skipping caused by CRISPR-generated mutations
por: Sharpe, Joshua J., et al.
Publicado: (2017)

On demand CRISPR-mediated RNA N6-methyladenosine editing
por: Xu, Ying, et al.
Publicado: (2022)

The power of unbiased phenotypic screens – cellulose as a first receptor for the Schitoviridae phage S6 of Erwinia amylovora
por: Römling, Ute
Publicado: (2022)

The body's integrated repair kit: Studying mesenchymal stem cells for better ligament repair
por: Häfner, Sophia Julia
Publicado: (2019)

The Cpf1 CRISPR-Cas protein expands genome-editing tools
por: Fagerlund, Robert D., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_hjbrpesgku4gegmulockqhlrfp